Literature DB >> 16548989

Liquid-based cytology improves productivity in cervical cytology screening.

B Doyle1, C O'Farrell, E Mahoney, L Turner, D Magee, D Gibbons.   

Abstract

OBJECTIVES: The ThinPrep test was introduced into our institution on a phased basis over 3 years between January 2002 and December 2004. This study set out to assess its effect on productivity (as measured by output of cases per medical scientist per day) during the changeover period. Numbers of high and low-grade lesions and of unsatisfactory slides were also monitored.
METHODS: The percentage conversion from conventional preparation to liquid-based cytology (LBC) and output of cases per medical scientist per day were calculated from our database at 6-month intervals. The average backlog, average number of cases received per month and percentage of unsatisfactory and abnormal cases were calculated similarly.
RESULTS: Over the study period 92 084 cases were received. The percentage of cases using ThinPrep increased: from 9% in January 2002 to 73% in December 2004. During the study there was an increase in output from 17.0 to 22.3 cases per medical scientist per day, representing a 31% improvement at 73% conversion. Numbers of unsatisfactory cases decreased substantially and the numbers of low and high-grade diagnoses were relatively constant.
CONCLUSIONS: The change to ThinPrep has improved productivity and decreased the number of unsatisfactory cases. There was no adverse effect on quality during the changeover.

Mesh:

Year:  2006        PMID: 16548989     DOI: 10.1111/j.1365-2303.2006.00338.x

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  7 in total

1.  The advantages of incorporating liquid-based cytology (TACAS™) in mass screening for cervical cancer.

Authors:  Yoshihito Yokoyama; Masayuki Futagami; Jun Watanabe; Atsushi Sakuraba; Kazuma Nagasawa; Hidetoshi Maruyama; Shigemi Sato
Journal:  Hum Cell       Date:  2016-01-06       Impact factor: 4.174

Review 2.  [Who performs gynecological cytology and how?].

Authors:  D Schmidt; H H Neumann
Journal:  Pathologe       Date:  2015-11       Impact factor: 1.011

3.  Newly developed liquid-based cytology. TACAS™: cytological appearance and HPV testing using liquid-based sample.

Authors:  Kaneyuki Kubushiro; Hideki Taoka; Nobuyuki Sakurai; Yasuhiro Yamamoto; Akiko Kurasaki; Yasuyuki Asakawa; Minoru Iwahara; Kei Takahashi
Journal:  Hum Cell       Date:  2011-06-09       Impact factor: 4.174

4.  Comparison of conventional and liquid-based cytology, and human papillomavirus testing using SurePath preparation in Japan.

Authors:  Hideki Taoka; Yasuhiro Yamamoto; Nobuyuki Sakurai; Mami Fukuda; Yasuyuki Asakawa; Akiko Kurasaki; Toshiaki Oharaseki; Kaneyuki Kubushiro
Journal:  Hum Cell       Date:  2010-11-17       Impact factor: 4.174

5.  Cytological Evaluation and REBA HPV-ID HPV Testing of Newly Developed Liquid-Based Cytology, EASYPREP: Comparison with SurePath.

Authors:  Youn Soo Lee; Gyungyub Gong; Jin Hee Sohn; Ki Sung Ryu; Jung Hun Lee; Shin Kwang Khang; Kyung-Ja Cho; Yong-Man Kim; Chang Suk Kang
Journal:  Korean J Pathol       Date:  2013-06-25

6.  Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study.

Authors: 
Journal:  BMJ       Date:  2009-07-28

7.  Barriers to adoption of recent technology in cervical screening.

Authors:  Darshana Jhala; Isam Eltoum
Journal:  Cytojournal       Date:  2007-08-16       Impact factor: 2.091

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.